Genetics of HCM and role of genetic testing

1Citations
Citations of this article
5Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Since 1989, major advances have been made in our understanding of the genetic basis of HCM. Our genetic advances have led to a complete re-definition of HCM as a complex medical genetic disorder of the sarcomere. To date, over 1,300 mutations in at least 13 disease genes have been identified in patients with HCM. This genetic information has had its greatest impact in the setting of predictive testing in at-risk family members. The genetic testing process in HCM requires a multidisciplinary approach, which includes the cardiologist, genetic counselor, geneticists, and patient support groups. Careful phenotyping of HCM patients, comprehensive pre- and post- test genetic counseling, careful interpretation of the genetic reports, and systematic application of the genetic result in the setting of the HCM family are all key components of care. The latest genetic technologies, including whole genome sequencing, will likely translate to a greater understanding of the genetic and molecular underpinnings of HCM.

Cite

CITATION STYLE

APA

Semsarian, C., & Ingles, J. (2015). Genetics of HCM and role of genetic testing. In Hypertrophic Cardiomyopathy: Foreword by Bernard Gersh and Historical Context by Eugene Braunwald (pp. 77–84). Springer-Verlag London Ltd. https://doi.org/10.1007/978-1-4471-4956-9_6

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free